Drugs

How to Navigate CDER Workshop for Advocacy Groups

The Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), sponsored a public workshop entitled “Navigating CDER: What You Should Know for Effective Engagement.” The purpose of this public workshop was to help the public and patient advocacy groups gain a better understanding of how to effectively engage CDER.

FDA Voice Blog: A 'Roadmap' for Navigating Patient Advocacy 

DATE, TIME AND LOCATION

March 31, 2016, from 8:30 a.m. to 5 p.m. FDA White Oak Campus

10903 New Hampshire Avenue
The Great Room (Room A, B and C)
Silver Spring, MD, 20993

Agenda (PDF - 41KB)

Navigating CDER Transcript from March 31, 2016 Workshop (PDF - 718KB)

Meeting Materials

FDA Campus Information

Links to Navigating CDER Workshop held on March 31st

FOR FURTHER INFORMATION CONTACT

CONTACT: NAV-CDER@fda.hhs.gov.

TRANSCRIPTS

A transcript of the workshop will be available for review at the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD  20852, and on the Internet at http://www.regulations.gov approximately 30 days after the workshop.  Transcripts will also be available in either hard copy or on CD-ROM, after submission of a Freedom of Information request.  The Freedom of Information office address is available on the Agency’s Web site at http://www.fda.gov.

Page Last Updated: 04/29/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.